Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Abbvie Inc | 272.0B | 22.0x | +12.19% |
Amgen Inc | 131.8B | 24.2x | +0.08% |
Bayer AG | 56.8B | 24.9x | -25.46% |
Catalent Inc | 19.0B | 39.2x | +28.57% |
Dr Reddy's Laboratories Ltd | 9.2B | 38.1x | -2.39% |
Eisai Co Ltd | 12.7B | 37.1x | +4.01% |
Eli Lilly and Co | 310.9B | 49.1x | +18.88% |
Emergent BioSolutions Inc | 1.7B | 11.2x | +27.49% |
GSK plc | 110.0B | 17.9x | +36.01% |
Horizon Therapeutics PLC | 19.0B | 22.5x | --- |
Johnson & Johnson | 468.8B | 24.1x | +5.65% |
Merck & Co Inc | 234.3B | 17.1x | +28.17% |
Novartis AG | 202.4B | 7.8x | +30.61% |
Novo Nordisk A/S | 193.9B | 37.4x | +6.74% |
Organon & Co | 8.7B | 6.5x | --- |
Pacira Biosciences Inc | 2.7B | 69.2x | --- |
Pfizer Inc | 289.7B | 11.9x | +27.43% |
Royalty Pharma PLC | 26.2B | 43.4x | --- |
Viatris Inc | 12.7B | 75.6x | --- |
Amneal Pharmaceuticals Inc | 1.0B | 314.0x | --- |
Amphastar Pharmaceuticals Inc | 1.7B | 22.1x | +43.27% |
Assertio Holdings Inc | 148.6M | 50.2x | --- |
Bon Natural Life Ltd | 19.6M | 2.9x | --- |
Bristol-Myers Squibb Co | 161.7B | 27.2x | +3.27% |
Catalyst Pharmaceuticals Inc | 760.6M | 18.0x | --- |
China BCT Pharmacy Group Inc | 3.8K | 0.0x | --- |
Collegium Pharmaceutical Inc | 629.9M | 20.7x | --- |
Corcept Therapeutics Inc | 2.7B | 28.7x | +66.36% |
Cyanotech Corp | 17.4M | 8.2x | --- |
Earth Science Tech Inc | 1.3M | 0.4x | --- |
Grove Inc | 67.5M | 25.2x | --- |
Harmony Biosciences Holdings Inc | 3.1B | 68.7x | --- |
Incyte Corp | 17.6B | 19.0x | +51.40% |
Innoviva Inc | 1.1B | 7.0x | +42.80% |
Integrated Biopharma Inc | 14.7M | 2.3x | +40.73% |
Invitro International | 1.6M | 200.0x | -17.03% |
LifeVantage Corp | 54.6M | 6.4x | +16.55% |
Natural Alternatives International Inc | 62.2M | 6.0x | +3.26% |
Organogenesis Holdings Inc | 683.1M | 8.2x | --- |
Prestige Consumer Healthcare Inc | 3.0B | 14.8x | +25.44% |
Qilian International Holding Group Ltd | 70.8M | 20.3x | --- |
Roche Holding AG | 274.0B | 20.0x | +7.78% |
Sanofi SA | 128.1B | 18.3x | +7.84% |
SIGA Technologies Inc | 925.4M | 14.6x | --- |
Takeda Pharmaceutical Co Ltd | 44.8B | 26.6x | -0.05% |
Taro Pharmaceutical Industries Ltd | 1.5B | 24.6x | -32.51% |
United-Guardian Inc | 67.7M | 15.7x | +12.54% |
Adamis Pharmaceuticals Corp | 79.8M | -2.6x | --- |
Aerie Pharmaceuticals Inc | 412.3M | -5.6x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
| Company | Dividend Yield |
|---|---|
United-Guardian, Inc. | 10.18% |
Takeda Pharmaceutical Co Ltd (ADR) | 8.01% |
GSK plc (ADR) | 4.59% |
Viatris Inc | 4.57% |
Novartis AG (ADR) | 3.95% |